COEP
Coeptis Therapeutics Inc
NASDAQ: COEP · HEALTHCARE · BIOTECHNOLOGY
$16.40
+1.17% today
Updated 2026-04-24
Market cap
$102.06M
P/E ratio
—
P/S ratio
74.88x
EPS (TTM)
$-2.81
Dividend yield
—
52W range
$7 – $21
Volume
0.0M
Coeptis Therapeutics Inc (COEP) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2004 | 2005 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $1.55M | $-417025.00 | $-839060.00 | $-90066.00 | $-3.14M | $-4.49M | $-3.88M | $-3.88M | $-6.65M | $-8.60M |
| Capital expenditures | $0.00 | $0.00 | $2793.00 | $35.00 | $0.00 | $1.75M | $0.00 | $0.00 | $4.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | — | — | — | — | $0.00 | $1.90M | $122391.00 | $477503.00 | $1.10M | $1.22M |
| Free cash flow | $1.55M | $-417025.00 | $-841853.00 | $-90101.00 | $-3.14M | $-6.24M | $-3.88M | $-3.88M | $-6.65M | $-8.60M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | $77595.00 | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — |